Keyphrases
Clinical Development
100%
Cancer-related
100%
Cancer Vaccine
100%
Efficacy Trial
100%
Development Paradigm
100%
Biologic Activity
66%
Immune Response
50%
Phase II Trial
50%
Cytotoxic Agents
50%
Therapeutic Vaccine
50%
Combination Therapy
33%
Randomized Phase II Trial
33%
Well-defined
33%
Developmental Processes
16%
Clinical Trials
16%
Clinical Benefit
16%
Pharmaceutical Industry
16%
Follow-up Time
16%
Clinical Characteristics
16%
U.S. Food
16%
Further Development
16%
Informed Decision-making
16%
Molecular Markers
16%
Clinical Activity
16%
Phase II Study
16%
Heterogeneous Groups
16%
Clinical Endpoints
16%
Historical Controls
16%
Progressive Disease
16%
Early Response
16%
Biologic Markers
16%
Rapidly Progressive
16%
Statistical Methods
16%
Immune Markers
16%
Host Immune Response
16%
Neoadjuvant Setting
16%
Unique Characteristics
16%
Tumor Response Rate
16%
Trial Design
16%
Vaccine Trial
16%
Consensus Process
16%
Vaccine Effectiveness
16%
Metastatic Setting
16%
Biologic Features
16%
Molecular Response
16%
Developmental Issues
16%
Oncology Drug Development
16%
Early Decision
16%
General Type
16%
Endpoint Control
16%
Adaptive Design
16%
2-phase
16%
Clinical Development Plan
16%
Safety Database
16%
Biotechnology Industry
16%
Design Elements
16%
Trigger Points
16%
Medicine and Dentistry
Biological Product
100%
Tumor Vaccine
100%
Immune Response
37%
Cytotoxic Agent
37%
Clinical Trial
25%
Combination Therapy
25%
Neoplasm
12%
Disease
12%
Oncology
12%
Decision Making
12%
Health Care Cost
12%
Clinical Study
12%
Statistical Analysis
12%
Arm
12%
Immune System
12%
Progressive Disease
12%
Molecular Marker
12%
Immunity
12%
Vaccine
12%
Trigger Point
12%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Product
100%
Tumor Vaccine
100%
Cytotoxic Agent
37%
Clinical Trial
25%
Disease
25%
Combination Therapy
25%
Neoplasm
12%
Clinical Study
12%
Molecular Marker
12%
Drug Development
12%
Vaccine
12%
Biochemistry, Genetics and Molecular Biology
Immune Response
100%
Clinical Trial
66%
Immunity
66%
Genetic Marker
33%
Clinical Study
33%
Decision Making
33%
Trigger Point
33%